Galmed Pharmaceuticals Ltd. Cash And Cash Equivalents At Carrying Value

• Galmed Pharmaceuticals Ltd. showed a decrease of -14.3% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
• This data is from Galmed Pharmaceuticals Ltd.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
• XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 15 years of available data (2011 to 2025), Galmed Pharmaceuticals Ltd.'s Cash And Cash Equivalents At Carrying Value has grown by 2,629.5%.
• Historical annual values: Fiscal year 2025: $3.99 million | Fiscal year 2024: $4.65 million | Fiscal year 2023: $2.86 million | Fiscal year 2022: $2.02 million | Fiscal year 2021: $2.88 million | Fiscal year 2020: $6.95 million | Fiscal year 2019: $15.93 million | Fiscal year 2018: $24.16 million | Fiscal year 2017: $13.02 million | Fiscal year 2016: $3.10 million | Fiscal year 2015: $4.16 million | Fiscal year 2014: $23.74 million | Fiscal year 2013: $137.0 thousand | Fiscal year 2012: $718.0 thousand | Fiscal year 2011: $146.0 thousand.
• Data sourced from SEC EDGAR public filings as of June 24, 2026.

Last verified: June 24, 2026